Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02503631 · ClinicalTrials.gov registry record
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
A clinical trial, sponsored by Exact Sciences Corporation.
- Terminated
- Registry status
- 397
- Enrollment target
NCT02503631: Clinical Trial study, sponsored by Exact Sciences Corporation.
NCT02503631 is a clinical trial that was terminated before completion, run by Exact Sciences Corporation. The registered enrollment target is 397 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02503631 was terminated before completion, sponsored by Exact Sciences Corporation.
- TERMINATED
- Registry status
- 397 participants
- Enrollment target
Study Summary
The primary objective of this study is to obtain de-identified, clinically characterized, stool and plasma specimens for use in assessing new markers for the detection of neoplasms of the digestive tract.
Interventions
- DEVICE Stool Sample Collection Kit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 397 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-09 |
Why NCT02503631 stopped before completion
NCT02503631 is an observational study that tracks outcomes without assigning an intervention. The registered 397 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Stool Sample Collection Kit is the first listed.
NCT02503631 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02503631 about?
NCT02503631 is a clinical study titled "Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers". The primary objective of this study is to obtain de-identified, clinically characterized, stool and plasma specimens for use in assessing new markers for the detection of neoplasms of the digestive tract.
What is the current status of trial NCT02503631?
This trial is currently terminated. The enrollment target is 397 participants. The study started on 2014-10. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02503631?
The interventions under investigation include: Stool Sample Collection Kit (DEVICE).
Who is sponsoring clinical trial NCT02503631?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00601939 · 397 participants · NA
Effectiveness of Empowerment Group Sessions for Treating Suicidal African American Women in Abusive Relationships
- NCT04115254 · 397 participants · NA
Stereotactic Magnetic Resonance Guided Radiation Therapy
- NCT05365581 · 398 participants · Phase 1
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- NCT05633615 · 396 participants · Phase 2
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia